Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionAvestar Capital, LLC
Latest Disclosed Ownership11,219 shares
Latest Disclosed Value $ 1,151,921
Avestar Capital, LLC reports 1.32% increase in ownership of ABL / Abbott Laboratories

On May 13, 2026 - Avestar Capital, LLC filed a 13F-HR form disclosing ownership of 11,219 shares of Abbott Laboratories (DE:ABL) valued at $996,472 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 11,073 shares of Abbott Laboratories. This represents a change in shares of 1.32% during the quarter. The current value of the position is $843,893 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 11,219 146 1.32 1,152 -17.02 0.0740
2026-02-10 2025-12-31 13F ABBOTT LABS COM 002824100 11,073 -492 -4.25 1,387 -10.46 0.0899
2025-11-07 2025-09-30 13F ABBOTT LABS COM 002824100 11,565 -1,254 -9.78 1,549 -11.13 0.1014
2025-08-13 2025-06-30 13F ABBOTT LABS COM 002824100 12,819 1,848 16.84 1,744 19.79 0.1191
2025-05-14 2025-03-31 13F ABBOTT LABS COM 002824100 10,971 722 7.04 1,455 25.54 0.1263
2025-01-29 2024-12-31 13F ABBOTT LABS COM 002824100 10,249 1,406 15.90 1,159 14.98 0.0985
2024-11-13 2024-09-30 13F ABBOTT LABS COM 002824100 8,843 973 12.36 1,008 23.38 0.1037
2024-08-08 2024-06-30 13F ABBOTT LABS COM 002824100 7,870 -147 -1.83 818 -10.32 0.0840
2024-05-10 2024-03-31 13F ABBOTT LABS COM 002824100 8,017 1,892 30.89 911 35.16 0.0956
2024-02-12 2023-12-31 13F ABBOTT LABS COM 002824100 6,125 1,429 30.43 674 48.46 0.0764
2023-10-20 2023-09-30 13F ABBOTT LABS COM 002824100 4,696 12 0.26 455 -10.98 0.0647
2023-08-02 2023-06-30 13F ABBOTT LABS COM 002824100 4,684 -643 -12.07 511 -5.38 0.0818
2023-04-20 2023-03-31 13F ABBOTT LABS COM 002824100 5,327 -469 -8.09 539 -15.25 0.0962
2023-01-20 2022-12-31 13F ABBOTT LABS COM 002824100 5,796 322 5.88 636 20.00 0.1152
2022-10-26 2022-09-30 13F ABBOTT LABS COM 002824100 5,474 -1,615 -22.78 530 -31.17 0.1351
2022-07-28 2022-06-30 13F ABBOTT LABS COM 002824100 7,089 618 9.55 770 0.52 0.1896
2022-04-26 2022-03-31 13F ABBOTT LABS COM 002824100 6,471 646 11.09 766 -6.59 0.1223
2022-02-01 2021-12-31 13F ABBOTT LABS COM 002824100 5,825 -246 -4.05 820 14.37 0.1003
2021-11-09 2021-09-30 13F ABBOTT LABS COM 002824100 6,071 593 10.83 717 12.91 0.0917
2021-08-03 2021-06-30 13F ABBOTT LABS COM 002824100 5,478 -72 -1.30 635 -5.79 0.0851
2021-05-03 2021-03-31 13F ABBOTT LABS COM 002824100 5,550 -931 -14.37 674 -5.07 0.1504
2021-02-01 2020-12-31 13F ABBOTT LABS COM 002824100 6,481 440 7.28 710 7.90 0.1971
2020-10-29 2020-09-30 13F ABBOTT LABS COM 002824100 6,041 -5,709 -48.59 658 -38.73 0.2169
2020-07-29 2020-06-30 13F ABBOTT LABS COM 002824100 11,750 6,937 144.13 1,074 182.63 0.4746
2020-05-12 2020-03-31 13F ABBOTT LABS COM 002824100 4,813 -478 -9.03 380 -17.21 0.2076
2020-02-14 2019-12-31 13F ABBOTT LABS COM 002824100 5,291 482 10.02 459 14.18 0.2593
2019-11-15 2019-09-30 13F/A-1 ABBOTT LABORATORIES COM 002824100 4,809 317 7.06 402 12.92 0.2499
2019-11-14 2019-09-30 13F ABBOTT LABORATORIES COM 002824100 4,809 317 402 0.2499
2019-08-06 2019-06-30 13F ABBOTT LABORATORIES COM 002824100 4,492 33 0.74 356 5.95 0.2256
2019-05-09 2019-03-31 13F ABBOTT LABORATORIES COM 002824100 4,459 -1,403 -23.93 336 -16.83 0.2207
2019-01-25 2018-12-31 13F ABBOTT LABORATORIES COM 002824100 5,862 -753 -11.38 404 -12.36 0.2760
2018-10-23 2018-09-30 13F ABBOTT LABORATORIES COM 002824100 6,615 836 14.47 461 41.41 0.2665
2018-08-10 2018-06-30 13F ABBOTT LABORATORIES COM 002824100 5,779 -308 -5.06 326 -6.32 0.2061
2018-05-10 2018-03-31 13F ABBOTT LABORATORIES COM 002824100 6,087 604 11.02 348 18.77 0.2262
2018-02-14 2017-12-31 13F ABBOTT LABORATORIES COM 002824100 5,483 5,483 293 0.2189
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.